Identification of immune-relevant factors conferring sarcoidosis genetic risk

American Journal of Respiratory and Critical Care Medicine

Volumn 192, Issue 6, 2015, Pages 727-736

  Fischer, Annegret ^a   Ellinghaus, David ^a   Nutsua, Marcel ^a   Hofmann, Sylvia ^a   Montgomery, Courtney G ^b   Iannuzzi, Michael C ^c   Rybicki, Benjamin A ^d   Petrek, Martin ^e   Mrazek, Frantisek ^e   Pabst, Stefan ^f   Grohè, Christian ^g   Grunewald, Johan ^h   Ronninger, Marcus ^h   Eklund, Anders ^h   Padyukov, Leonid ⁱ   Mihailovic Vucinic, Violeta ^j   Jovanovic, Dragana ^j   Sterclova, Martina ^k   Homolka, Jiri ^l   Nöthen, Markus M ^m   Herms, Stefan ^m,n   Gieger, Christian ^o   Strauch, Konstantin ^o,p   Winkelmann, Juliane ^o,q   Boehm, Bernhard O ^r,s,t   Brand, Stephan ^p   Büning, Carsten ^u   Schürmann, Manfred ^v   Ellinghaus, Eva ^a   Baurecht, Hansjörg ^q,w   Lieb, Wolfgang ^a   Nebel, Almut ^a   Müller Quernheim, Joachim ^x   Franke, Andre ^a   Schreiber, Stefan ^a,w   more..

^a UNIVERSITY OF KIEL   (Germany)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

^d HENRY FORD HOSPITAL   (United States)

^e PALACKÝ UNIVERSITY   (Czech Republic)

^f Pneumologische Praxis   (Germany)

^g Klinik für Pneumologie Evangelische Lungenklinik Berlin Buch   (Germany)

^h KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁱ KAROLINSKA INSTITUTE   (Sweden)

^j CLINICAL CENTER OF SERBIA   (Serbia)

^k FAKULTNÍ THOMAYEROVA NEMOCNICE   (Czech Republic)

^l CHARLES UNIVERSITY   (Czech Republic)

^m UNIVERSITY OF BONN   (Germany)

ⁿ UNIVERSITY OF BASEL   (Switzerland)

^o INSTITUTE OF EPIDEMIOLOGY   (Germany)

^p UNIVERSITY OF MUNICH   (Germany)

^q TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^r UNIVERSITY HOSPITAL ULM   (Germany)

^s NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^t IMPERIAL COLLEGE LONDON   (United Kingdom)

^u CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^v UNIVERSITY OF LÜBECK   (Germany)

^w UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^x UNIVERSITY OF FREIBURG   (Germany)

more..

Author keywords

Association; BTNL2; HLA; IL23; Immunochip

Indexed keywords

HLA B ANTIGEN; HLA DPB1 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P40; TRANSCRIPTION FACTOR RELA; GENETIC MARKER;

ADULT; AFRICAN AMERICAN; ARTICLE; BINDING SITE; CHROMOSOME 12Q; CHROMOSOME 2Q; CHROMOSOME 4Q; CHROMOSOME 5Q; CONTROLLED STUDY; EUROPEAN; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HERITABILITY; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROMOTER REGION; SARCOIDOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; CASE CONTROL STUDY; CAUCASIAN; ETHNOLOGY; EUROPE; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; IMMUNOLOGY;

ADULT; AFRICAN AMERICANS; AGED; CASE-CONTROL STUDIES; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SARCOIDOSIS;

EID: 84942245587     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201503-0418OC     Document Type: Article

References (64)

1. Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Muller-Quernheim J. Sarcoidosis. Lancet 2014;383:1155-1167.
2. Valentonyte R, Hampe J, Huse K, Rosenstiel P, Albrecht M, Stenzel A, Nagy M, Gaede KI, Franke A, Haesler R, et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 2005;37:357-364.
3. Li Y, Wollnik B, Pabst S, Lennarz M, Rohmann E, Gillissen A, Vetter H, GrohèC. BTNL2 gene variant and sarcoidosis. Thorax 2006;61:273-274.
4. Rybicki BA, Walewski JL, Maliarik MJ, Kian H, Iannuzzi MC; ACCESS Research Group. The BTNL2 gene and sarcoidosis susceptibility in African Americans and whites. Am J Hum Genet 2005;77:491-499.
5. Hofmann S, Franke A, Fischer A, Jacobs G, Nothnagel M, Gaede KI, Schürmann M, Müller-Quernheim J, Krawczak M, Rosenstiel P, et al. Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Nat Genet 2008;40:1103-1106.
6. Li Y, Pabst S, Kubisch C, GrohèC, Wollnik B. First independent replication study confirms the strong genetic association of ANXA11 with sarcoidosis. Thorax 2010;65:939-940.
7. Morais A, Lima B, Peixoto M, Melo N, Alves H, Marques JA, Delgado L. Annexin A11 gene polymorphism (R230C variant) and sarcoidosis in a Portuguese population. Tissue Antigens 2013;82: 186-191.
8. Levin AM, Iannuzzi MC, Montgomery CG, Trudeau S, Datta I, McKeigue P, Fischer A, Nebel A, Rybicki BA. Association of ANXA11 genetic variation with sarcoidosis in African Americans and European Americans. Genes Immun 2013;14:13-18.
9. Fischer A, Schmid B, Ellinghaus D, Nothnagel M, Gaede KI, Schürmann M, Lipinski S, Rosenstiel P, Zissel G, Höhne K, et al. A novel sarcoidosis risk locus for Europeans on chromosome 11q13.1. Am J Respir Crit Care Med 2012;186:877-885.
10. Müller-Quernheim J, Schürmann M, Hofmann S, Gaede KI, Fischer A, Prasse A, Zissel G, Schreiber S. Genetics of sarcoidosis. Clin Chest Med 2008;29:391-414, viii.
11. Fischer A, Nothnagel M, Franke A, Jacobs G, Saadati HR, Gaede KI, Rosenstiel P, Schürmann M, Müller-Quernheim J, Schreiber S, et al. Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes. Eur Respir J 2011;37: 610-616.
12. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, et al. A genomewide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006;314:1461-1463.
13. Silverberg MS, Cho JH, Rioux JD, McGovern DP, Wu J, Annese V, Achkar JP, Goyette P, Scott R, Xu W, et al. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet 2009;41:216-220.
14. Nair RP, Ruether A, Stuart PE, Jenisch S, Tejasvi T, Hiremagalore R, Schreiber S, Kabelitz D, Lim HW, Voorhees JJ, et al. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J Invest Dermatol 2008;128:1653-1661.
15. Rueda B, Orozco G, Raya E, Fernandez-Sueiro JL, Mulero J, Blanco FJ, Vilches C, González-Gay MA, Martin J. The IL23R Arg381Gln nonsynonymous polymorphism confers susceptibility to ankylosing spondylitis. Ann Rheum Dis 2008;67:1451-1454.
16. Cortes A, Brown MA. Promise and pitfalls of the Immunochip. Arthritis Res Ther 2011;13:101.
17. Parkes M, Cortes A, van Heel DA, Brown MA. Genetic insights into common pathways and complex relationships among immunemediated diseases. Nat Rev Genet 2013;14:661-673.
18. Trynka G, Hunt KA, Bockett NA, Romanos J, Mistry V, Szperl A, Bakker SF, Bardella MT, Bhaw-Rosun L, Castillejo G, et al.; Spanish Consortium on the Genetics of Coeliac Disease (CEGEC); PreventCD Study Group; Wellcome Trust Case Control Consortium (WTCCC). Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 2011;43:1193-1201.
19. Tsoi LC, Spain SL, Knight J, Ellinghaus E, Stuart PE, Capon F, Ding J, Li Y, Tejasvi T, Gudjonsson JE, et al.; Collaborative Association Study of Psoriasis (CASP); Genetic Analysis of Psoriasis Consortium; Psoriasis Association Genetics Extension; Wellcome Trust Case Control Consortium 2. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet 2012;44:1341-1348.
20. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, et al.; International IBD Genetics Consortium (IIBDGC). Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012;491:119-124.
21. Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, Andreassen OA, Weersma RK, Weismüller TJ, Eksteen B, et al.; UKPSCSC Consortium; International IBD Genetics Consortium; International PSC Study Group. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet 2013;45:670-675.
22. Liu JZ, Almarri MA, Gaffney DJ, Mells GF, Jostins L, Cordell HJ, Ducker SJ, Day DB, Heneghan MA, Neuberger JM, et al.; UK Primary Biliary Cirrhosis (PBC) Consortium; Wellcome Trust Case Control Consortium 3. Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis. Nat Genet 2012;44: 1137-1141.
23. Ellinghaus D, Baurecht H, Esparza-Gordillo J, Rodríguez E, Matanovic A, Marenholz I, Hübner N, Schaarschmidt H, Novak N, Michel S, et al. High-density genotyping study identifies four new susceptibility loci for atopic dermatitis. Nat Genet 2013;45:808-812.
24. Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C, Shah TS, Spencer C, Booth D, Goris A, et al.; International Multiple Sclerosis Genetics Consortium (IMSGC); Wellcome Trust Case Control Consortium 2 (WTCCC2); International IBD Genetics Consortium (IIBDGC). Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 2013;45:1353-1360.
25. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736-755.
26. Gabriel S, Ziaugra L, Tabbaa D. SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet 2009;60: 2.12.1-2.12.18.
27. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-575.
28. Dilthey AT, Moutsianas L, Leslie S, McVean G. HLA∗IMP-an integrated framework for imputing classical HLA alleles from SNP genotypes. Bioinformatics 2011;27:968-972.
29. Kim HS, Choi D, Lim LL, Allada G, Smith JR, Austin CR, Doyle TM, Goodwin KA, Rosenbaum JT, Martin TM. Association of interleukin 23 receptor gene with sarcoidosis. Dis Markers 2011;31:17-24.
30. Adrianto I, Lin CP, Hale JJ, Levin AM, Datta I, Parker R, Adler A, Kelly JA, Kaufman KM, Lessard CJ, et al. Genome-wide association study of African and European Americans implicates multiple shared and ethnic specific loci in sarcoidosis susceptibility. PLoS One 2012;7: e43907.
31. Fischer A, Grunewald J, Spagnolo P, Nebel A, Schreiber S, Müller-Quernheim J. Genetics of sarcoidosis. Semin Respir Crit Care Med 2014;35:296-306.
32. Grunewald J, Brynedal B, Darlington P, Nisell M, Cederlund K, Hillert J, Eklund A. Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients. Respir Res 2010;11:25.
33. Xu Z, Taylor JA. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res 2009;37:W600-W605.
34. Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, Doerks T, Julien P, Roth A, Simonovic M, et al. STRING 8-a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 2009;37:D412-D416.
35. Ellinghaus D, Ellinghaus E, Nair RP, Stuart PE, Esko T, Metspalu A, Debrus S, Raelson JV, Tejasvi T, Belouchi M, et al. Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci. Am J Hum Genet 2012;90:636-647.
36. Takaki S, Sauer K, Iritani BM, Chien S, Ebihara Y, Tsuji K, Takatsu K, Perlmutter RM. Control of B cell production by the adaptor protein lnk. Definition of a conserved family of signal-modulating proteins. Immunity 2000;13:599-609.
37. Fitau J, Boulday G, Coulon F, Quillard T, Charreau B. The adaptor molecule Lnk negatively regulates tumor necrosis factor-alphadependent VCAM-1 expression in endothelial cells through inhibition of the ERK1 and -2 pathways. J Biol Chem 2006;281:20148-20159.
38. Zhernakova A, Elbers CC, Ferwerda B, Romanos J, Trynka G, Dubois PC, de Kovel CG, Franke L, Oosting M, Barisani D, et al.; Finnish Celiac Disease Study Group. Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection. Am J Hum Genet 2010;86:970-977.
39. Talati M, West J, Zaynagetdinov R, Hong CC, Han W, Blackwell T, Robinson L, Blackwell TS, Lane K. BMP pathway regulation of and by macrophages. PLoS One 2014;9:e94119.
40. Leng D, Huan C, Xie T, Liang J, Wang J, Dai H, Wang C, Jiang D. Metaanalysis of genetic programs between idiopathic pulmonary fibrosis and sarcoidosis. PLoS One 2013;8:e71059.
41. Couturier N, Bucciarelli F, Nurtdinov RN, Debouverie M, Lebrun-Frenay C, Defer G, Moreau T, Confavreux C, Vukusic S, Cournu-Rebeix I, et al. Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility. Brain 2011;134:693-703.
42. Patterson KC, Franek BS, Müller-Quernheim J, Sperling AI, Sweiss NJ, Niewold TB. Circulating cytokines in sarcoidosis: phenotype-specific alterations for fibrotic and non-fibrotic pulmonary disease. Cytokine 2013;61:906-911.
43. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357:2153-2165.
44. Facco M, Cabrelle A, Teramo A, Olivieri V, Gnoato M, Teolato S, Ave E, Gattazzo C, Fadini GP, Calabrese F, et al. Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax 2011;66:144-150.
45. Ten Berge B, Paats MS, Bergen IM, van den Blink B, Hoogsteden HC, Lambrecht BN, Hendriks RW, Kleinjan A. Increased IL-17A expression in granulomas and in circulating memory T cells in sarcoidosis. Rheumatology (Oxford) 2012;51:37-46.
46. Sandborn WJ, Gasink C, Gao LL, Blank MA, Johanns J, Guzzo C, Sands BE, Hanauer SB, Targan S, Rutgeerts P, et al.; CERTIFI Study Group. Ustekinumab induction and maintenance therapy in refractory Crohn's disease. N Engl J Med 2012;367:1519-1528.
47. Kopylov U, Afif W, Cohen A, Bitton A, Wild G, Bessissow T, Wyse J, Al-Taweel T, Szilagyi A, Seidman E. Subcutaneous ustekinumab for the treatment of anti-TNF resistant Crohn's disease-the McGill experience. J Crohn's Colitis 2014;8:1516-1522.
48. Judson MA, Baughman RP, Costabel U, Drent M, Gibson KF, Raghu G, Shigemitsu H, Barney JB, Culver DA, Hamzeh NY, et al. Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis. Eur Respir J 2014;44:1296-1307.
49. Wijnen PA, Cremers JP, Nelemans PJ, Erckens RJ, Hoitsma E, Jansen TL, Bekers O, Drent M. Association of the TNF-a G-308A polymorphism with TNF-inhibitor response in sarcoidosis. Eur Respir J 2014;43:1730-1739.
50. Spagnolo P, Sato H, Grutters JC, Renzoni EA, Marshall SE, Ruven HJ, Wells AU, Tzouvelekis A, van Moorsel CH, van den Bosch JM, et al. Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis. Tissue Antigens 2007;70:219-227.
51. Suzuki H, Ota M, Meguro A, Katsuyama Y, Kawagoe T, Ishihara M, Asukata Y, Takeuchi M, Ito N, Shibuya E, et al. Genetic characterization and susceptibility for sarcoidosis in Japanese patients: risk factors of BTNL2 gene polymorphisms and HLA class II alleles. Invest Ophthalmol Vis Sci 2012;53:7109-7115.
52. Cozier Y, Ruiz-Narvaez E, McKinnon C, Berman J, Rosenberg L, Palmer J. Replication of genetic loci for sarcoidosis in US black women: data from the Black Women's Health Study. Hum Genet 2013;132:803-810.
53. Morais A, Lima B, Peixoto MJ, Alves H, Marques A, Delgado L. BTNL2 gene polymorphism associations with susceptibility and phenotype expression in sarcoidosis. Respir Med 2012;106:1771-1777.
54. Milman N, Svendsen CB, Nielsen FC, van Overeem Hansen T. The BTNL2 A allele variant is frequent in Danish patients with sarcoidosis. Clin Respir J 2011;5:105-111.
55. Wennerström A, Pietinalho A, Lasota J, Salli K, Surakka I, Seppänen M, Selroos O, Lokki ML. Major histocompatibility complex class II and BTNL2 associations in sarcoidosis. Eur Respir J 2013;42:550-553.
56. Idali F, Wikèn M, Wahlström J, Mellstedt H, Eklund A, Rabbani H, Grunewald J. Reduced Th1 response in the lungs of HLA-DRB1.∗0301 patients with pulmonary sarcoidosis. Eur Respir J 2006;27:451-459.
57. Grunewald J, Eklund A, Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 2004;169:696-702.
58. Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok CC, French M, Mallal S, Christiansen F. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999;167:257-274.
59. Morris DL, Taylor KE, Fernando MM, Nititham J, Alarcón-Riquelme ME, Barcellos LF, Behrens TW, Cotsapas C, Gaffney PM, Graham RR, et al.; International MHC and Autoimmunity Genetics Network; Systemic Lupus Erythematosus Genetics Consortium. Unraveling multiple MHC gene associations with systemic lupus erythematosus: model choice indicates a role for HLA alleles and non-HLA genes in Europeans. Am J Hum Genet 2012; 91:778-793.
60. Lympany PA, Petrek M, Southcott AM, Newman Taylor AJ, Welsh KI, du Bois RM. HLA-DPB polymorphisms: Glu 69 association with sarcoidosis. Eur J Immunogenet 1996;23:353-359.
61. Maliarik MJ, Chen KM, Major ML, Sheffer RG, Popovich J Jr, Rybicki BA, Iannuzzi MC. Analysis of HLA-DPB1 polymorphisms in African-Americans with sarcoidosis. Am J Respir Crit Care Med 1998;158: 111-114.
62. Schürmann M, Bein G, Kirsten D, Schlaak M, Müller-Quernheim J, Schwinger E. HLA-DQB1 and HLA-DPB1 genotypes in familial sarcoidosis. Respir Med 1998;92:649-652.
63. Rossman MD, Thompson B, Frederick M, Maliarik M, Iannuzzi MC, Rybicki BA, Pandey JP, Newman LS, Magira E, Beznik-Cizman B, et al.; ACCESS Group. HLA-DRB1∗1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 2003;73: 720-735.
64. Richeldi L, Sorrentino R, Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 1993;262:242-244.